Literature DB >> 11910574

Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients.

Robert S Brown1, K Shiva Kumar, Mark W Russo, Milan Kinkhabwala, Dianne L Rudow, Patricia Harren, Steven Lobritto, Jean C Emond.   

Abstract

The Model for End-Stage Liver Disease (MELD) has been proposed as a replacement for the Child-Turcotte-Pugh (CTP) classification to stratify patients for prioritization for orthotopic liver transplantation (OLT). Improved classification of patients with decompensated cirrhosis might allow timely OLT before the development of life-threatening complications, reducing the number of critically ill patients listed as United Network for Organ Sharing (UNOS) status 2A at the time of OLT. We compared the ability of the MELD and CTP scores to predict pre-OLT disease severity, as well as outcome and resource utilization post-OLT. Data from 42 consecutive UNOS status 2A patients undergoing OLT at a single center were used to calculate MELD and CTP scores at the time of status 2A listing. Multivariate analysis was used to determine the relationship between these scores and pre-OLT disease severity measures, survival post-OLT, and measures of resource use post-OLT. The MELD was superior to CTP score in predicting pre-OLT requirements for mechanical ventilation and dialysis. Neither score correlated with the resource utilization parameters studied. Only two patients died within 3 months post-OLT; neither score was predictive of survival in this cohort. In summary, the MELD is superior to CTP score in estimating pre-OLT disease severity in UNOS status 2A patients and thus may help risk stratify status 2A or decompensated status 2B OLT candidates and optimize the timing of OLT. However, neither score correlated with resource use post-OLT in the strata of critically ill patients.

Entities:  

Mesh:

Year:  2002        PMID: 11910574     DOI: 10.1053/jlts.2002.31340

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  32 in total

1.  A prospective cohort study of risk prediction in simultaneous pancreas and kidney transplantation.

Authors:  H A Khambalia; Z Moinuddin; A M Summers; A Tavakoli; R Pararajasingam; T Campbell; R Dhanda; B Forgacs; T Augustine; D van Dellen
Journal:  Ann R Coll Surg Engl       Date:  2015-08-14       Impact factor: 1.891

2.  Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.

Authors:  Ming Zhang; Bo Li; Lu-Nan Yan; Fei Yin; Tian-Fu Wen; Yong Zeng; Ji-Chun Zhao; Yu-Kui Ma
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

3.  Pre- and Peri-Operative Factors Associated with Chronic Critical Illness in Liver Transplant Recipients.

Authors:  Nicholas E Ingraham; Christopher J Tignanelli; Jeremiah Menk; Jeffrey G Chipman
Journal:  Surg Infect (Larchmt)       Date:  2019-10-16       Impact factor: 2.150

4.  Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver.

Authors:  Roni Atalay; Reyhan Ersoy; Aylin Bolat Demirezer; Fatma Ebru Akın; Sefika Burcak Polat; Bekir Cakir; Osman Ersoy
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

5.  Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.

Authors:  Maricar F Malinis; Shu Chen; Heather G Allore; Vincent J Quagliarello
Journal:  Ann Transplant       Date:  2014-09-26       Impact factor: 1.530

6.  Pre-transplant MELD and sodium MELD scores are poor predictors of graft failure and mortality after liver transplantation.

Authors:  Jacek B Cywinski; Edward J Mascha; Jing You; Daniel I Sessler; Leonardo Kapural; Maged Argalious; Brian M Parker
Journal:  Hepatol Int       Date:  2011-02-17       Impact factor: 6.047

7.  Superior Mesenteric Arterial Flow Pattern is Associated with Major Adverse Events in Adults with Fontan Circulation.

Authors:  Makoto Mori; Kayoko Shioda; Robert W Elder; Maria A Pernetz; Fred H Rodriguez; Alicia Rangosch; Brian E Kogon; Wendy M Book
Journal:  Pediatr Cardiol       Date:  2016-03-31       Impact factor: 1.655

8.  Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

Authors:  Hany Dabbous; Mohammad Sakr; Sara Abdelhakam; Iman Montasser; Mohamed Bahaa; Hany Said; Mahmoud El-Meteini
Journal:  World J Hepatol       Date:  2016-08-08

Review 9.  Laparoscopic liver resection for the patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Zenichi Morise
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-16

10.  Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies.

Authors:  John D Roberson Ii; Andrew M McDonald; Craig J Baden; Chee Paul Lin; Rojymon Jacob; Omer L Burnett Iii
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.